While these data show there are multiple routes to transformation of post-MPN sAML, the single cell genomics clearly show that the leukemia-initiating mutations are not always present within the JAK2-mutant clones and can arise independently and outcompete the MPN cells to drive transformation. The gene discussed is JAK2; the disease is leukemia.